JESSICA HILZ: Open Payments
NPI 1659121754 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,135 in 21 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $475 · 2025 $1,135
Food & beverage: $1,135
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 11 | $372 |
| AstraZeneca Pharmaceuticals LP | 2 | $236 |
| Alnylam Pharmaceuticals Inc. | 1 | $135 |
| Gilead Sciences, Inc. | 1 | $128 |
| BETA BIONICS, INC. | 1 | $109 |
| Cipher Pharmaceuticals US LLC | 1 | $55 |
| Ascensia Diabetes Care Us Inc. | 1 | $29 |
| Novo Nordisk Inc | 1 | $28 |
| Insulet Corporation | 1 | $25 |
| Lilly USA, LLC | 1 | $16 |
Products named: MINIMED 780G, ONPATTRO, Descovy, BREZTRI, iLet Bionic Pancreas, Natroba, Omnipod, MOUNJARO.
Industry payments across PA — which companies pay providers there.
